15 Deoxy Δ12,14 PGJ2 Induces Procoagulant Activity in Cultured Human Endothelial Cells

Summary 15 deoxy Δ12,14 PGJ2 (15d-PGJ2), a high affinity ligand of peroxisome proliferator-activated receptor γ (PPAR γ has been proposed to act as a negative feedback regulator of the inflammatory response. We investigated the effect of 15d-PGJ2 on the anticoagulant property of endothelial cells. 15d-PGJ2 stimulated a moderate but sustained increase in tissue factor (TF) activity in HUVECs and EA.hy926 cells while causing a partial loss of thrombomodulin (TM) activity. When cells were co-treated with 15d-PGJ2 and TNF-α, the subsequent elevation of TF activity was synergistically increased over that of cells treated with TNF-α, alone and the decline of TF activity after 24 h was less marked than TNF-α, alone. The induction of TF by 15d-PGJ2 alone and in combination with TNF-α, was reduced in the presence of PD 98059, suggesting the participation of the MEK/ERK pathway. The thiazolidinedione PPAR γ agonist ciglitazone had no effect on TF levels but reduced the expression of endothelial protein C receptor. The ability of 15d-PGJ2 to enhance a procoagulant phenotype arising from TNF-α, suggests a pro-inflammatory role for the prostaglandin.

[1]  B. Rovin,et al.  A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma. , 2001, Biochemical and biophysical research communications.

[2]  P. Libby,et al.  PPARalpha activators inhibit tissue factor expression and activity in human monocytes. , 2001, Circulation.

[3]  B. Binder,et al.  Specificity, diversity, and convergence in VEGF and TNF‐α signaling events leading to tissue factor up regulation via EGR‐1 in endothelial cells , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  M. Lazar Progress in cardiovascular biology: PPAR for the course , 2001, Nature Medicine.

[5]  C. Glass,et al.  15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway , 2000 .

[6]  D. Bishop-Bailey Peroxisome proliferator‐activated receptors in the cardiovascular system , 2000, British journal of pharmacology.

[7]  C. Esmon,et al.  Metalloproteolytic Release of Endothelial Cell Protein C Receptor* , 2000, The Journal of Biological Chemistry.

[8]  G. Natoli,et al.  Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase , 2000, Nature.

[9]  J. Holder,et al.  PPAR-gamma agonists: therapeutic role in diabetes, inflammation and cancer. , 2000, Trends in pharmacological sciences.

[10]  V. Kakkar,et al.  Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[11]  T. Hla,et al.  Endothelial Cell Apoptosis Induced by the Peroxisome Proliferator-activated Receptor (PPAR) Ligand 15-Deoxy-Δ12,14-prostaglandin J2 * , 1999, The Journal of Biological Chemistry.

[12]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[13]  B. Binder,et al.  Vascular endothelial cell growth factor-induced tissue factor expression in endothelial cells is mediated by EGR-1. , 1999, Blood.

[14]  C. Reutelingsperger,et al.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.

[15]  K. Colston,et al.  Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. , 1997, The Journal of endocrinology.

[16]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.

[17]  K. Nagata,et al.  Anticoagulant effects of retinoic acids on leukemia cells. , 1996, Blood.

[18]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[19]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[20]  N. Mackman Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  F. Bach,et al.  Regulation of the Tissue Factor Promoter in Endothelial Cells , 1995, The Journal of Biological Chemistry.

[22]  B. Spiegelman,et al.  15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. , 1995, Cell.

[23]  C. Esmon,et al.  Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. , 1994, The Journal of biological chemistry.

[24]  M. Scully,et al.  Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. , 1994, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  N. Mackman,et al.  Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites , 1991, The Journal of experimental medicine.

[26]  J. Sadler,et al.  Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. , 1991, Blood.

[27]  J. Sadler,et al.  Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. , 1989, The Journal of biological chemistry.

[28]  C. Esmon,et al.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. , 1989, Blood.

[29]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[31]  F. Fitzpatrick,et al.  Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. , 1983, The Journal of biological chemistry.

[32]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.